000			02210 a2200637 4500
005			20250514070558.0
264		0	_c20030626
008			200306s 0 0 eng d
022			_a0741-238X
024	7		_a10.1007/BF02850116 _2doi
040			_aNLM _beng _cNLM
100	1		_aNetland, Peter A
245	0	0	_aBrimonidine Purite and bimatoprost compared with timolol and latanoprost in patients with glaucoma and ocular hypertension. _h[electronic resource]
260			_bAdvances in therapy _c
300			_a20-30 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Topical
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAmides
650	0	4	_aBimatoprost
650	0	4	_aBrimonidine Tartrate
650	0	4	_aCloprostenol _xanalogs & derivatives
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGlaucoma, Open-Angle _xdiagnosis
650	0	4	_aHumans
650	0	4	_aIntraocular Pressure _xdrug effects
650	0	4	_aLatanoprost
650	0	4	_aLipids _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOcular Hypertension _xdiagnosis
650	0	4	_aOphthalmic Solutions
650	0	4	_aProbability
650	0	4	_aProstaglandins F, Synthetic _xadministration & dosage
650	0	4	_aQuinoxalines _xadministration & dosage
650	0	4	_aReference Values
650	0	4	_aRisk Assessment
650	0	4	_aSensitivity and Specificity
650	0	4	_aSeverity of Illness Index
650	0	4	_aSingle-Blind Method
650	0	4	_aTimolol _xadministration & dosage
650	0	4	_aTonometry, Ocular
650	0	4	_aTreatment Outcome
700	1		_aMichael, Mroz
700	1		_aRosner, Sarah A
700	1		_aKatzman, Barry
700	1		_aMacy, Jonathan I
773	0		_tAdvances in therapy _gvol. 20 _gno. 1 _gp. 20-30
856	4	0	_uhttps://doi.org/10.1007/BF02850116 _zAvailable from publisher's website
999			_c12559038 _d12559038